Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
October 4, 1995
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis
H Shimada, D O Stram, J Chatten, et al.
Cancer Research
|
October 1, 1986
Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas
Y Shiloh, B Korf, N E Kohl, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, J G Villablanca, K K Matthay, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, T J Moss, S A Feig, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Response of neuroblastoma to retinoic acid in vitro and in vivo
C P Reynolds, D J Kane, P A Einhorn, et al.
The Journal of Pediatrics
|
November 1, 1982
Reversal of enterocolitis-associated combined immunodeficiency by plasma therapy
R A Cannon, P M Blum, M E Ament, et al.
Oncogene
|
April 1, 1993
Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas
A Leone, R C Seeger, C M Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study
M F Ozkaynak, P M Sondel, M D Krailo, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma
L M Choi, N W Kim, J J Zuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
K K Matthay, K DeSantes, B Hasegawa, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
October 4, 1995
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis
H Shimada, D O Stram, J Chatten, et al.
Cancer Research
|
October 1, 1986
Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas
Y Shiloh, B Korf, N E Kohl, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, J G Villablanca, K K Matthay, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Bone marrow transplantation for poor prognosis neuroblastoma
R C Seeger, T J Moss, S A Feig, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Response of neuroblastoma to retinoic acid in vitro and in vivo
C P Reynolds, D J Kane, P A Einhorn, et al.
The Journal of Pediatrics
|
November 1, 1982
Reversal of enterocolitis-associated combined immunodeficiency by plasma therapy
R A Cannon, P M Blum, M E Ament, et al.
Oncogene
|
April 1, 1993
Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas
A Leone, R C Seeger, C M Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study
M F Ozkaynak, P M Sondel, M D Krailo, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma
L M Choi, N W Kim, J J Zuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
K K Matthay, K DeSantes, B Hasegawa, et al.
Page
of 16